Select Medical Holdings Co. (NYSE:SEM) to Issue $0.06 Quarterly Dividend

Select Medical Holdings Co. (NYSE:SEM - Get Free Report) declared a quarterly dividend on Thursday, February 13th, Wall Street Journal reports. Shareholders of record on Monday, March 3rd will be given a dividend of 0.0625 per share by the health services provider on Thursday, March 13th. This represents a $0.25 annualized dividend and a yield of 1.31%. The ex-dividend date of this dividend is Monday, March 3rd.

Select Medical has increased its dividend payment by an average of 10.1% annually over the last three years. Select Medical has a dividend payout ratio of 17.9% indicating that its dividend is sufficiently covered by earnings. Analysts expect Select Medical to earn $1.41 per share next year, which means the company should continue to be able to cover its $0.25 annual dividend with an expected future payout ratio of 17.7%.

Select Medical Trading Up 3.4 %

Shares of NYSE SEM traded up $0.63 during midday trading on Tuesday, hitting $19.16. The company's stock had a trading volume of 1,697,424 shares, compared to its average volume of 894,509. The firm has a market cap of $2.48 billion, a P/E ratio of 11.61, a price-to-earnings-growth ratio of 0.64 and a beta of 1.45. Select Medical has a 12-month low of $16.20 and a 12-month high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The business's 50 day moving average is $19.07 and its two-hundred day moving average is $27.81.

Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. As a group, equities research analysts expect that Select Medical will post 1.17 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Royal Bank of Canada cut their target price on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating on the stock in a research report on Monday. UBS Group cut their price objective on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a report on Friday, January 3rd. StockNews.com upgraded Select Medical from a "hold" rating to a "buy" rating in a report on Friday. Finally, Benchmark upgraded shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target on the stock in a report on Monday. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Select Medical has a consensus rating of "Moderate Buy" and a consensus target price of $27.25.

Insider Buying and Selling at Select Medical

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the company's stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the sale, the vice president now owns 30,356 shares of the company's stock, valued at approximately $605,602.20. This represents a 14.12 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 19.14% of the stock is owned by corporate insiders.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.